Kirontech UK Ltd 09540297 false 2025-01-01 2025-12-31 2025-12-31 The principal activity of the company is the provision of specifically develpoed software to healthcare providers, in order to collate and analyse data. Digita Accounts Production Advanced 6.30.9574.0 true false true 09540297 2025-01-01 2025-12-31 09540297 2025-12-31 09540297 bus:OrdinaryShareClass1 2025-12-31 09540297 core:FurtherSpecificReserve1ComponentTotalEquity 2025-12-31 09540297 core:RetainedEarningsAccumulatedLosses 2025-12-31 09540297 core:ShareCapital 2025-12-31 09540297 core:SharePremium 2025-12-31 09540297 core:CurrentFinancialInstruments 2025-12-31 09540297 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 09540297 core:Non-currentFinancialInstruments 2025-12-31 09540297 core:Non-currentFinancialInstruments core:AfterOneYear 2025-12-31 09540297 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-12-31 09540297 core:FurnitureFittings 2025-12-31 09540297 core:OfficeEquipment 2025-12-31 09540297 bus:SmallEntities 2025-01-01 2025-12-31 09540297 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 09540297 bus:FullAccounts 2025-01-01 2025-12-31 09540297 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 09540297 bus:RegisteredOffice 2025-01-01 2025-12-31 09540297 bus:Director1 2025-01-01 2025-12-31 09540297 bus:Director2 2025-01-01 2025-12-31 09540297 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 09540297 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 09540297 bus:Agent1 2025-01-01 2025-12-31 09540297 core:FurtherSpecificReserve1ComponentTotalEquity 2025-01-01 2025-12-31 09540297 core:RetainedEarningsAccumulatedLosses 2025-01-01 2025-12-31 09540297 core:ShareCapital 2025-01-01 2025-12-31 09540297 core:SharePremium 2025-01-01 2025-12-31 09540297 core:ComputerSoftware 2025-01-01 2025-12-31 09540297 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-01-01 2025-12-31 09540297 core:ComputerEquipment 2025-01-01 2025-12-31 09540297 core:FurnitureFittings 2025-01-01 2025-12-31 09540297 core:OfficeEquipment 2025-01-01 2025-12-31 09540297 1 2025-01-01 2025-12-31 09540297 countries:EnglandWales 2025-01-01 2025-12-31 09540297 2024-12-31 09540297 core:FurtherSpecificReserve1ComponentTotalEquity 2024-12-31 09540297 core:FurtherSpecificReserve1ComponentTotalEquity core:PreviouslyStatedAmount 2024-12-31 09540297 core:FurtherSpecificReserve1ComponentTotalEquity core:PriorPeriodIncreaseDecrease 2024-12-31 09540297 core:RetainedEarningsAccumulatedLosses 2024-12-31 09540297 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-12-31 09540297 core:RetainedEarningsAccumulatedLosses core:PriorPeriodIncreaseDecrease 2024-12-31 09540297 core:ShareCapital 2024-12-31 09540297 core:ShareCapital core:PreviouslyStatedAmount 2024-12-31 09540297 core:ShareCapital core:PriorPeriodIncreaseDecrease 2024-12-31 09540297 core:SharePremium 2024-12-31 09540297 core:SharePremium core:PreviouslyStatedAmount 2024-12-31 09540297 core:SharePremium core:PriorPeriodIncreaseDecrease 2024-12-31 09540297 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-12-31 09540297 core:FurnitureFittings 2024-12-31 09540297 core:OfficeEquipment 2024-12-31 09540297 core:PreviouslyStatedAmount 2024-12-31 09540297 core:PriorPeriodIncreaseDecrease 2024-12-31 09540297 2024-01-01 2024-12-31 09540297 2024-12-31 09540297 bus:OrdinaryShareClass1 2024-12-31 09540297 core:CurrentFinancialInstruments 2024-12-31 09540297 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 09540297 core:Non-currentFinancialInstruments 2024-12-31 09540297 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 09540297 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-12-31 09540297 core:FurnitureFittings 2024-12-31 09540297 core:OfficeEquipment 2024-12-31 09540297 core:FurtherSpecificReserve1ComponentTotalEquity 2024-01-01 2024-12-31 09540297 core:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 09540297 core:ShareCapital 2024-01-01 2024-12-31 09540297 core:SharePremium 2024-01-01 2024-12-31 09540297 2023-12-31 09540297 core:FurtherSpecificReserve1ComponentTotalEquity 2023-12-31 09540297 core:RetainedEarningsAccumulatedLosses 2023-12-31 09540297 core:ShareCapital 2023-12-31 09540297 core:SharePremium 2023-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 09540297

Kirontech UK Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 December 2025

 

Kirontech UK Ltd

Contents

Company Information

1

Directors' Report

2

Accountants' Report

3

Profit and Loss Account

4

Statement of Comprehensive Income

5

Balance Sheet

6 to 7

Statement of Changes in Equity

8

Notes to the Unaudited Financial Statements

9 to 16

 

Kirontech UK Ltd

Company Information

Directors

Mr Omar Rene Chebli

Mr Demetri Dinopoulos

Registered office

9 Hills Road
Cambridge
England
CB2 1GE

Accountants

Wilton Lyndon Limited
Chartered Certified Accountants5 Ducketts Wharf
South Street
Bishop's Stortford
Hertfordshire
CM23 3AR

 

Kirontech UK Ltd

Directors' Report for the Year Ended 31 December 2025

The directors present their report and the financial statements for the year ended 31 December 2025.

Directors of the company

The directors who held office during the year were as follows:

Mr Omar Rene Chebli

Mr Demetri Dinopoulos

Principal activity

The principal activity of the company is the provision of specifically develpoed software to healthcare providers, in order to collate and analyse data.

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 29 April 2026 and signed on its behalf by:
 

.........................................
Mr Omar Rene Chebli
Director

.........................................
Mr Demetri Dinopoulos
Director

 

Chartered Certified Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Kirontech UK Ltd
for the Year Ended 31 December 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Kirontech UK Ltd for the year ended 31 December 2025 as set out on pages 4 to 16 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at https://www.accaglobal.com/gb/en/member/standards/rules-and-standards/rulebook.html.

This report is made solely to the Board of Directors of Kirontech UK Ltd, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Kirontech UK Ltd and state those matters that we have agreed to state to the Board of Directors of Kirontech UK Ltd, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/gb/en/technical-activities/technical-resources-search/2009/
october/factsheet-163-audit-exempt-companies.html. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Kirontech UK Ltd and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Kirontech UK Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and loss of Kirontech UK Ltd. You consider that Kirontech UK Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Kirontech UK Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

Wilton Lyndon Limited
Chartered Certified Accountants
5 Ducketts Wharf
South Street
Bishop's Stortford
Hertfordshire
CM23 3AR

29 April 2026

 

Kirontech UK Ltd

Profit and Loss Account for the Year Ended 31 December 2025

Note

2025
£

2024
£

Turnover

 

822,787

829,546

Cost of sales

 

(661,260)

(227,861)

Gross profit

 

161,527

601,685

Administrative expenses

 

(1,548,897)

(2,019,186)

Operating loss

 

(1,387,370)

(1,417,501)

Other interest receivable and similar income

 

3,721

5,233

Interest payable and similar expenses

 

(21,066)

(14,956)

   

(17,345)

(9,723)

Loss before tax

5

(1,404,715)

(1,427,224)

Tax on loss

 

220,499

339,672

Loss for the financial year

 

(1,184,216)

(1,087,552)

The above results were derived from continuing operations.

The company has no recognised gains or losses for the year other than the results above.

 

Kirontech UK Ltd

Statement of Comprehensive Income for the Year Ended 31 December 2025

2025
£

2024
£

Loss for the year

(1,184,216)

(1,087,552)

Total comprehensive income for the year

(1,184,216)

(1,087,552)

 

Kirontech UK Ltd

(Registration number: 09540297)
Balance Sheet as at 31 December 2025

Note

2025
£

2024
£

Fixed assets

 

Intangible assets

6

2,564

11,517

Tangible assets

7

14,428

46,336

 

16,992

57,853

Current assets

 

Debtors

8

579,536

598,321

Cash at bank and in hand

 

92,307

750,584

 

671,843

1,348,905

Creditors: Amounts falling due within one year

9

(4,271,078)

(4,188,217)

Net current liabilities

 

(3,599,235)

(2,839,312)

Total assets less current liabilities

 

(3,582,243)

(2,781,459)

Creditors: Amounts falling due after more than one year

9

-

(3,333)

Net liabilities

 

(3,582,243)

(2,784,792)

Capital and reserves

 

Called up share capital

10

370

370

Share premium reserve

3,505,838

3,505,838

Other reserves

-

2,885,436

Retained earnings

(7,088,451)

(9,176,436)

Shareholders' deficit

 

(3,582,243)

(2,784,792)

 

Kirontech UK Ltd

(Registration number: 09540297)
Balance Sheet as at 31 December 2025

For the financial year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.

Approved and authorised by the Board on 29 April 2026 and signed on its behalf by:
 

.........................................
Mr Omar Rene Chebli
Director

.........................................
Mr Demetri Dinopoulos
Director

 

Kirontech UK Ltd

Statement of Changes in Equity for the Year Ended 31 December 2025

Share capital
£

Share premium
£

Other reserves
£

Retained earnings
£

Total
£

At 1 January 2025

370

3,505,838

2,885,436

(9,176,436)

(2,784,792)

Prior period adjustment

-

-

-

386,765

386,765

At 1 January 2025 (As restated)

370

3,505,838

2,885,436

(8,789,671)

(2,398,027)

Loss for the year

-

-

-

(1,184,216)

(1,184,216)

Transfers

-

-

-

2,885,436

2,885,436

Other movements on reserves

-

-

(2,885,436)

-

(2,885,436)

At 31 December 2025

370

3,505,838

-

(7,088,451)

(3,582,243)

Share capital
£

Share premium
£

Other reserves
£

Retained earnings
£

Total
£

At 1 January 2024

370

3,505,838

2,885,436

(8,088,884)

(1,697,240)

Loss for the year

-

-

-

(1,087,552)

(1,087,552)

At 31 December 2024

370

3,505,838

2,885,436

(9,176,436)

(2,784,792)

 

Kirontech UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
9 Hills Road
Cambridge
CB2 1GE
England

These financial statements were authorised for issue by the Board on 29 April 2026.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The directors have given consideration to the fact that the company continues to make an operating loss and is in a net liability position. The company has continued to build on its existing client relationships to secure long term projects, as well as working diligently towards forming and maintaining new client relationships. The company expects to add new customers in 2025 while maintaining the existing client pipeline. The company will also claim R&D tax credits.

As, under the company's current plans, the company's cash income is not expcted to cover the company's cash outflows for the next 12 months, the company is currently reliant on financial support from its parent company, Kirontech UK Holding Ltd, which, in turn, is reliant on obtaining additional financing in order to continue to provide support to the company so it can meet its current objectives. If this additional financing is not obtained, the company has a contingency plan in place which would enable it to service its existing contracts. The directors are confident that this additional financing can be raised and even in the worst case scenario do not consider there to be a material uncertainty in relation to going concern.

Therefore, the financial statements have been prepared on a going concern basis.

 

Kirontech UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Foreign currency transactions and balances

The company's functional and presentational currency is GBP.

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures and fittings

20% on cost

Computer equipment

20% on cost

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

 

Kirontech UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

Asset class

Amortisation method and rate

Computer software

20% on cost

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Kirontech UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 18 (2024 - 18).

4

Auditors' remuneration

2025
£

2024
£

Audit of the financial statements

37,000

33,240


 

5

Loss before tax

Arrived at after charging/(crediting)

2025
£

2024
£

Depreciation expense

18,990

18,640

Amortisation expense

7,568

7,569

 

Kirontech UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

6

Intangible assets

Computer software
£

Total
£

Cost or valuation

At 1 January 2025

37,844

37,844

Disposals

(23,933)

(23,933)

At 31 December 2025

13,911

13,911

Amortisation

At 1 January 2025

26,327

26,327

Amortisation charge

7,568

7,568

Amortisation eliminated on disposals

(22,548)

(22,548)

At 31 December 2025

11,347

11,347

Carrying amount

At 31 December 2025

2,564

2,564

At 31 December 2024

11,517

11,517

 

Kirontech UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

7

Tangible assets

Fixtures and fittings
£

Computer equipment
£

Total
£

Cost or valuation

At 1 January 2025

65,293

100,433

165,726

Additions

-

6,201

6,201

Disposals

(65,293)

(72,781)

(138,074)

At 31 December 2025

-

33,853

33,853

Depreciation

At 1 January 2025

44,203

75,187

119,390

Charge for the year

8,750

10,240

18,990

Eliminated on disposal

(52,953)

(66,002)

(118,955)

At 31 December 2025

-

19,425

19,425

Carrying amount

At 31 December 2025

-

14,428

14,428

At 31 December 2024

21,090

25,246

46,336

 

Kirontech UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

8

Debtors

Current

Note

2025
£

2024
£

Trade debtors

 

54,543

(21,551)

Amounts owed by related parties

16,996

-

Prepayments

 

4,880

35,929

Other debtors

 

503,117

583,943

   

579,536

598,321

9

Creditors

Creditors: amounts falling due within one year

Note

2025
£

2024
£

Due within one year

 

Loans and borrowings

11

3,333

10,000

Trade creditors

 

27,667

73,355

Amounts owed to group undertakings

4,055,239

3,943,878

Taxation and social security

 

54,681

-

Accruals and deferred income

 

121,869

36,681

Other creditors

 

8,289

124,303

 

4,271,078

4,188,217

Creditors: amounts falling due after more than one year

Note

2025
£

2024
£

Due after one year

 

Loans and borrowings

11

-

3,333

 

Kirontech UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

10

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Ordinary shares of £1 each

370

370

370

370

       

11

Loans and borrowings

Non-current loans and borrowings

2025
£

2024
£

Bank borrowings

-

3,333

Current loans and borrowings

2025
£

2024
£

Bank borrowings

3,333

10,000

12

Relationship between entity and parents

The parent of the smallest group in which these financial statements are consolidated is Kirontech UK Holding Ltd, incorporated in England and Wales.

The address of Kirontech UK Holding Ltd is:
4 Wellington Court, Wellington Street, Cambridge, CB1 1HZ